ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Research Report 2026
Published Date: 2026-03-05
|
Report Code: QYRE-Auto-17W2541
Home | Market Reports | Health| Health Conditions| Neurological Conditions
China Amyotrophic Lateral Sclerosis ALS Treatment Market Report Forecast 2021 2027
BUY CHAPTERS

Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Research Report 2026

Code: QYRE-Auto-17W2541
Report
2026-03-05
Pages:105
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Mitsubishi Tanabe Pharma
Sanofi
Mylan Pharma
Apotex
Glemark Generics
Covis Pharma
Sun Pharma
Lunan Pharma

Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size

The global Amyotrophic Lateral Sclerosis (ALS) Treatment market was valued at US$ 376 million in 2025 and is anticipated to reach US$ 643 million by 2032, at a CAGR of 8.1% from 2026 to 2032.

Amyotrophic Lateral Sclerosis (ALS) Treatment Market

Amyotrophic Lateral Sclerosis (ALS) Treatment Market

Amyotrophic lateral sclerosis (ALS) is also known as Lou Gehrig’s disease or Maladie De Charcot, it is a neurological disease that causes nerve cells to gradually break down and die.
The cause is not known in 90% to 95% of cases. The remaining 5–10% of cases are inherited from a person"s parents. About half of these genetic cases are due to one of two specific genes. The underlying mechanism involves damage to both upper and lower motor neurons. The diagnosis is based on a person"s signs and symptoms, with testing done to rule out other potential causes.
GlobalAmyotrophic Lateral Sclerosis (ALS) Treatment key players include Mitsubishi Tanabe Pharma, Sanofi, etc. Global top two manufacturers hold a share over 80%.
North America is the largest market, with a share about 60%, followed by Japan, and Europe, both have a share over 20 percent.
In terms of product, Edaravone (Radicava) is the largest segment, with a share over 75%. And in terms of application, the largest application is Hospital, followed by Drugs Store, etc.
This report delivers a comprehensive overview of the global Amyotrophic Lateral Sclerosis (ALS) Treatment market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Amyotrophic Lateral Sclerosis (ALS) Treatment. The Amyotrophic Lateral Sclerosis (ALS) Treatment market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Amyotrophic Lateral Sclerosis (ALS) Treatment market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Amyotrophic Lateral Sclerosis (ALS) Treatment manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Amyotrophic Lateral Sclerosis (ALS) Treatment Market Report

Report Metric Details
Report Name Amyotrophic Lateral Sclerosis (ALS) Treatment Market
Accounted market size in 2025 US$ 376 million
Forecasted market size in 2032 US$ 643 million
CAGR 8.1%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Riluzole
  • Edaravone (Radicava)
  • Other
Segment by Application
  • Hospital
  • Drugs Store
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Mitsubishi Tanabe Pharma, Sanofi, Mylan Pharma, Apotex, Glemark Generics, Covis Pharma, Sun Pharma, Lunan Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Amyotrophic Lateral Sclerosis (ALS) Treatment companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Amyotrophic Lateral Sclerosis (ALS) Treatment Market growing?

Ans: The Amyotrophic Lateral Sclerosis (ALS) Treatment Market witnessing a CAGR of 8.1% during the forecast period 2026-2032.

What is the Amyotrophic Lateral Sclerosis (ALS) Treatment Market size in 2032?

Ans: The Amyotrophic Lateral Sclerosis (ALS) Treatment Market size in 2032 will be US$ 643 million.

What is the market share of major companies in Amyotrophic Lateral Sclerosis (ALS) Treatment Market?

Ans: Global top two manufacturers hold a share over 80%.

What is the Amyotrophic Lateral Sclerosis (ALS) Treatment Market share by type?

Ans: In terms of product, Edaravone (Radicava) is the largest segment, with a share over 75%.

Who are the main players in the Amyotrophic Lateral Sclerosis (ALS) Treatment Market report?

Ans: The main players in the Amyotrophic Lateral Sclerosis (ALS) Treatment Market are Mitsubishi Tanabe Pharma, Sanofi, Mylan Pharma, Apotex, Glemark Generics, Covis Pharma, Sun Pharma, Lunan Pharma

What are the Application segmentation covered in the Amyotrophic Lateral Sclerosis (ALS) Treatment Market report?

Ans: The Applications covered in the Amyotrophic Lateral Sclerosis (ALS) Treatment Market report are Hospital, Drugs Store, Other

What are the Type segmentation covered in the Amyotrophic Lateral Sclerosis (ALS) Treatment Market report?

Ans: The Types covered in the Amyotrophic Lateral Sclerosis (ALS) Treatment Market report are Riluzole, Edaravone (Radicava), Other

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Riluzole
1.2.3 Edaravone (Radicava)
1.2.4 Other
1.3 Market by Application
1.3.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Drugs Store
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Perspective (2021–2032)
2.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Growth Trends by Region
2.2.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Historic Market Size by Region (2021–2026)
2.2.3 Amyotrophic Lateral Sclerosis (ALS) Treatment Forecasted Market Size by Region (2027–2032)
2.3 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Dynamics
2.3.1 Amyotrophic Lateral Sclerosis (ALS) Treatment Industry Trends
2.3.2 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Drivers
2.3.3 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Challenges
2.3.4 Amyotrophic Lateral Sclerosis (ALS) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Amyotrophic Lateral Sclerosis (ALS) Treatment Players by Revenue
3.1.1 Global Top Amyotrophic Lateral Sclerosis (ALS) Treatment Players by Revenue (2021–2026)
3.1.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Players (2021–2026)
3.2 Global Top Amyotrophic Lateral Sclerosis (ALS) Treatment Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue
3.4 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Concentration Ratio
3.4.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue in 2025
3.5 Global Key Players of Amyotrophic Lateral Sclerosis (ALS) Treatment Head Offices and Areas Served
3.6 Global Key Players of Amyotrophic Lateral Sclerosis (ALS) Treatment, Products and Applications
3.7 Global Key Players of Amyotrophic Lateral Sclerosis (ALS) Treatment, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Amyotrophic Lateral Sclerosis (ALS) Treatment Breakdown Data by Type
4.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Historic Market Size by Type (2021–2026)
4.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Forecasted Market Size by Type (2027–2032)
5 Amyotrophic Lateral Sclerosis (ALS) Treatment Breakdown Data by Application
5.1 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Historic Market Size by Application (2021–2026)
5.2 Global Amyotrophic Lateral Sclerosis (ALS) Treatment Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size (2021–2032)
6.2 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2021–2026)
6.4 North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size (2021–2032)
7.2 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2021–2026)
7.4 Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size (2021–2032)
8.2 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Region (2021–2026)
8.4 Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size (2021–2032)
9.2 Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2021–2026)
9.4 Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size (2021–2032)
10.2 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2021–2026)
10.4 Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Mitsubishi Tanabe Pharma
11.1.1 Mitsubishi Tanabe Pharma Company Details
11.1.2 Mitsubishi Tanabe Pharma Business Overview
11.1.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Introduction
11.1.4 Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2021–2026)
11.1.5 Mitsubishi Tanabe Pharma Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Amyotrophic Lateral Sclerosis (ALS) Treatment Introduction
11.2.4 Sanofi Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2021–2026)
11.2.5 Sanofi Recent Development
11.3 Mylan Pharma
11.3.1 Mylan Pharma Company Details
11.3.2 Mylan Pharma Business Overview
11.3.3 Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Introduction
11.3.4 Mylan Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2021–2026)
11.3.5 Mylan Pharma Recent Development
11.4 Apotex
11.4.1 Apotex Company Details
11.4.2 Apotex Business Overview
11.4.3 Apotex Amyotrophic Lateral Sclerosis (ALS) Treatment Introduction
11.4.4 Apotex Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2021–2026)
11.4.5 Apotex Recent Development
11.5 Glemark Generics
11.5.1 Glemark Generics Company Details
11.5.2 Glemark Generics Business Overview
11.5.3 Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Treatment Introduction
11.5.4 Glemark Generics Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2021–2026)
11.5.5 Glemark Generics Recent Development
11.6 Covis Pharma
11.6.1 Covis Pharma Company Details
11.6.2 Covis Pharma Business Overview
11.6.3 Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Introduction
11.6.4 Covis Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2021–2026)
11.6.5 Covis Pharma Recent Development
11.7 Sun Pharma
11.7.1 Sun Pharma Company Details
11.7.2 Sun Pharma Business Overview
11.7.3 Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Introduction
11.7.4 Sun Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2021–2026)
11.7.5 Sun Pharma Recent Development
11.8 Lunan Pharma
11.8.1 Lunan Pharma Company Details
11.8.2 Lunan Pharma Business Overview
11.8.3 Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Introduction
11.8.4 Lunan Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2021–2026)
11.8.5 Lunan Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Mitsubishi Tanabe Pharma
Sanofi
Mylan Pharma
Apotex
Glemark Generics
Covis Pharma
Sun Pharma
Lunan Pharma
List of Tables
 Table 1. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Riluzole
 Table 3. Key Players of Edaravone (Radicava)
 Table 4. Key Players of Other
 Table 5. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Region (US$ Million), 2021–2026
 Table 8. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Region (2021–2026)
 Table 9. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 10. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Region (2027–2032)
 Table 11. Amyotrophic Lateral Sclerosis (ALS) Treatment Market Trends
 Table 12. Amyotrophic Lateral Sclerosis (ALS) Treatment Market Drivers
 Table 13. Amyotrophic Lateral Sclerosis (ALS) Treatment Market Challenges
 Table 14. Amyotrophic Lateral Sclerosis (ALS) Treatment Market Restraints
 Table 15. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue by Players (US$ Million), 2021–2026
 Table 16. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Players (2021–2026)
 Table 17. Global Top Amyotrophic Lateral Sclerosis (ALS) Treatment Players by Tier (Tier 1, Tier 2, and Tier 3), based on Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue, 2025
 Table 18. Ranking of Global Top Amyotrophic Lateral Sclerosis (ALS) Treatment Companies by Revenue (US$ Million) in 2025
 Table 19. Global 5 Largest Players Market Share by Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue (CR5 and HHI), 2021–2026
 Table 20. Global Key Players of Amyotrophic Lateral Sclerosis (ALS) Treatment, Headquarters and Area Served
 Table 21. Global Key Players of Amyotrophic Lateral Sclerosis (ALS) Treatment, Products and Applications
 Table 22. Global Key Players of Amyotrophic Lateral Sclerosis (ALS) Treatment, Date of General Availability (GA)
 Table 23. Mergers and Acquisitions, Expansion Plans
 Table 24. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Type (US$ Million), 2021–2026
 Table 25. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Type (2021–2026)
 Table 26. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 27. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Type (2027–2032)
 Table 28. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (US$ Million), 2021–2026
 Table 29. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Application (2021–2026)
 Table 30. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 31. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue Market Share by Application (2027–2032)
 Table 32. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 33. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (US$ Million), 2021–2026
 Table 34. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (US$ Million), 2027–2032
 Table 35. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 36. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (US$ Million), 2021–2026
 Table 37. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (US$ Million), 2027–2032
 Table 38. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 39. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Region (US$ Million), 2021–2026
 Table 40. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Region (US$ Million), 2027–2032
 Table 41. Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 42. Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (US$ Million), 2021–2026
 Table 43. Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (US$ Million), 2027–2032
 Table 44. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 45. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (US$ Million), 2021–2026
 Table 46. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Country (US$ Million), 2027–2032
 Table 47. Mitsubishi Tanabe Pharma Company Details
 Table 48. Mitsubishi Tanabe Pharma Business Overview
 Table 49. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Product
 Table 50. Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (US$ Million), 2021–2026
 Table 51. Mitsubishi Tanabe Pharma Recent Development
 Table 52. Sanofi Company Details
 Table 53. Sanofi Business Overview
 Table 54. Sanofi Amyotrophic Lateral Sclerosis (ALS) Treatment Product
 Table 55. Sanofi Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (US$ Million), 2021–2026
 Table 56. Sanofi Recent Development
 Table 57. Mylan Pharma Company Details
 Table 58. Mylan Pharma Business Overview
 Table 59. Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Product
 Table 60. Mylan Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (US$ Million), 2021–2026
 Table 61. Mylan Pharma Recent Development
 Table 62. Apotex Company Details
 Table 63. Apotex Business Overview
 Table 64. Apotex Amyotrophic Lateral Sclerosis (ALS) Treatment Product
 Table 65. Apotex Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (US$ Million), 2021–2026
 Table 66. Apotex Recent Development
 Table 67. Glemark Generics Company Details
 Table 68. Glemark Generics Business Overview
 Table 69. Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Treatment Product
 Table 70. Glemark Generics Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (US$ Million), 2021–2026
 Table 71. Glemark Generics Recent Development
 Table 72. Covis Pharma Company Details
 Table 73. Covis Pharma Business Overview
 Table 74. Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Product
 Table 75. Covis Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (US$ Million), 2021–2026
 Table 76. Covis Pharma Recent Development
 Table 77. Sun Pharma Company Details
 Table 78. Sun Pharma Business Overview
 Table 79. Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Product
 Table 80. Sun Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (US$ Million), 2021–2026
 Table 81. Sun Pharma Recent Development
 Table 82. Lunan Pharma Company Details
 Table 83. Lunan Pharma Business Overview
 Table 84. Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Treatment Product
 Table 85. Lunan Pharma Revenue in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (US$ Million), 2021–2026
 Table 86. Lunan Pharma Recent Development
 Table 87. Research Programs/Design for This Report
 Table 88. Key Data Information from Secondary Sources
 Table 89. Key Data Information from Primary Sources
 Table 90. Authors List of This Report


List of Figures
 Figure 1. Amyotrophic Lateral Sclerosis (ALS) Treatment Picture
 Figure 2. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Type: 2025 vs 2032
 Figure 4. Riluzole Features
 Figure 5. Edaravone (Radicava) Features
 Figure 6. Other Features
 Figure 7. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size by Application (US$ Million), 2021–2032
 Figure 8. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Application: 2025 vs 2032
 Figure 9. Hospital Case Studies
 Figure 10. Drugs Store Case Studies
 Figure 11. Other Case Studies
 Figure 12. Amyotrophic Lateral Sclerosis (ALS) Treatment Report Years Considered
 Figure 13. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 14. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Region: 2025 vs 2032
 Figure 16. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Players in 2025
 Figure 17. Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 18. The Top 10 and 5 Players Market Share by Amyotrophic Lateral Sclerosis (ALS) Treatment Revenue in 2025
 Figure 19. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 20. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Country (2021–2032)
 Figure 21. United States Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Canada Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Country (2021–2032)
 Figure 25. Germany Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. France Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. U.K. Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Italy Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Russia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Ireland Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Region (2021–2032)
 Figure 33. China Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Japan Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. South Korea Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Southeast Asia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. India Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Australia & New Zealand Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Country (2021–2032)
 Figure 41. Mexico Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Brazil Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Treatment Market Share by Country (2021–2032)
 Figure 45. Israel Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Saudi Arabia Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. UAE Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. Mitsubishi Tanabe Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2021–2026)
 Figure 49. Sanofi Revenue Growth Rate in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2021–2026)
 Figure 50. Mylan Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2021–2026)
 Figure 51. Apotex Revenue Growth Rate in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2021–2026)
 Figure 52. Glemark Generics Revenue Growth Rate in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2021–2026)
 Figure 53. Covis Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2021–2026)
 Figure 54. Sun Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2021–2026)
 Figure 55. Lunan Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis (ALS) Treatment Business (2021–2026)
 Figure 56. Bottom-up and Top-down Approaches for This Report
 Figure 57. Data Triangulation
 Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Amyotrophic Lateral Sclerosis ALS Market Insights Forecast to 2030
Global Amyotrophic Lateral Sclerosis Therapeutics Market Insights Forecast to 2030
Global Amyotrophic Lateral Sclerosis ALS Devices Market Research Report 2024
Rare Neurodegenerative Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Spinal Muscular Atrophy Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Neurodegenerative Disease Market Insights Forecast to 2030
Global Spinal Muscular Atrophy SMA Treatment Market Research Report 2024
Global Amyotrophic Lateral Sclerosis Device Market Research Report 2025
Global Parkinson s Disease Treatment Market Insights Forecast to 2030
Global Alzheimer s Disease Treatments Market Research Report 2024
Global Neurodegenerative Disease Treatment Market Research Report 2024
Global Alzheimer s Disease Drug Market Insights Forecast to 2030
Global Alzheimer Treatment Drug Market Research Report 2025
Alzheimer Disease Genetic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Rilutek Market Insights Forecast to 2030
Global Neurologic Disorders Therapeutics Market Insights Forecast to 2030
Global TIGLUTIK Market Insights Forecast to 2030
Global Alzheimer s Disease Therapeutics and Diagnostics Market Insights Forecast to 2030
Global Teglutik Market Insights Forecast to 2030
Global Gene Therapy for Inherited Genetic Disorders Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions